Application of nanomaterials as an advanced strategy for the diagnosis, prevention, and treatment of viral diseases

Jong Woo Lim; Yu Rim Ahn; Geunseon Park; Hyun Ouk Kim; Seungjoo Haam

doi:10.3390/pharmaceutics13101570

Application of nanomaterials as an advanced strategy for the diagnosis, prevention, and treatment of viral diseases

Jong Woo Lim, Yu Rim Ahn, Geunseon Park, Hyun Ouk Kim, Seungjoo Haam

Department of Chemical and Biomolecular Engineering

Research output: Contribution to journal › Review article › peer-review

7 Citations (Scopus)

Abstract

The coronavirus disease (COVID-19) pandemic poses serious global health concerns with the continued emergence of new variants. The periodic outbreak of novel emerging and re-emerging infectious pathogens has elevated concerns and challenges for the future. To develop mitigation strategies against infectious diseases, nano-based approaches are being increasingly applied in diagnostic systems, prophylactic vaccines, and therapeutics. This review presents the properties of various nanoplatforms and discusses their role in the development of sensors, vectors, delivery agents, intrinsic immunostimulants, and viral inhibitors. Advanced nanomedical applications for infectious diseases have been highlighted. Moreover, physicochemical properties that confer physiological advantages and contribute to the control and inhibition of infectious diseases have been discussed. Safety concerns limit the commercial production and clinical use of these technologies in humans; however, overcoming these limitations may enable the use of nanomaterials to resolve current infection control issues via application of nanomaterials as a platform for the diagnosis, prevention, and treatment of viral diseases.

Original language	English
Article number	1570
Journal	Pharmaceutics
Volume	13
Issue number	10
DOIs	https://doi.org/10.3390/pharmaceutics13101570
Publication status	Published - 2021 Oct

Bibliographical note

Funding Information:
This work was supported by the National Research Foundation of Korea (NRF-2019R1I1A1 A01057005, NRF-2018M3A9E2022819, NRF-2021M3E5E3083400, and NRF-2021M3E5E3080565).

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

All Science Journal Classification (ASJC) codes

Pharmaceutical Science

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/pharmaceutics13101570

Cite this

@article{e1c06003139247429f964d5eb42fa5c4,

title = "Application of nanomaterials as an advanced strategy for the diagnosis, prevention, and treatment of viral diseases",

abstract = "The coronavirus disease (COVID-19) pandemic poses serious global health concerns with the continued emergence of new variants. The periodic outbreak of novel emerging and re-emerging infectious pathogens has elevated concerns and challenges for the future. To develop mitigation strategies against infectious diseases, nano-based approaches are being increasingly applied in diagnostic systems, prophylactic vaccines, and therapeutics. This review presents the properties of various nanoplatforms and discusses their role in the development of sensors, vectors, delivery agents, intrinsic immunostimulants, and viral inhibitors. Advanced nanomedical applications for infectious diseases have been highlighted. Moreover, physicochemical properties that confer physiological advantages and contribute to the control and inhibition of infectious diseases have been discussed. Safety concerns limit the commercial production and clinical use of these technologies in humans; however, overcoming these limitations may enable the use of nanomaterials to resolve current infection control issues via application of nanomaterials as a platform for the diagnosis, prevention, and treatment of viral diseases.",

author = "Lim, {Jong Woo} and Ahn, {Yu Rim} and Geunseon Park and Kim, {Hyun Ouk} and Seungjoo Haam",

note = "Funding Information: This work was supported by the National Research Foundation of Korea (NRF-2019R1I1A1 A01057005, NRF-2018M3A9E2022819, NRF-2021M3E5E3083400, and NRF-2021M3E5E3080565). Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2021",

month = oct,

doi = "10.3390/pharmaceutics13101570",

language = "English",

volume = "13",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "10",

}

TY - JOUR

T1 - Application of nanomaterials as an advanced strategy for the diagnosis, prevention, and treatment of viral diseases

AU - Lim, Jong Woo

AU - Ahn, Yu Rim

AU - Park, Geunseon

AU - Kim, Hyun Ouk

AU - Haam, Seungjoo

N1 - Funding Information: This work was supported by the National Research Foundation of Korea (NRF-2019R1I1A1 A01057005, NRF-2018M3A9E2022819, NRF-2021M3E5E3083400, and NRF-2021M3E5E3080565). Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2021/10

Y1 - 2021/10

N2 - The coronavirus disease (COVID-19) pandemic poses serious global health concerns with the continued emergence of new variants. The periodic outbreak of novel emerging and re-emerging infectious pathogens has elevated concerns and challenges for the future. To develop mitigation strategies against infectious diseases, nano-based approaches are being increasingly applied in diagnostic systems, prophylactic vaccines, and therapeutics. This review presents the properties of various nanoplatforms and discusses their role in the development of sensors, vectors, delivery agents, intrinsic immunostimulants, and viral inhibitors. Advanced nanomedical applications for infectious diseases have been highlighted. Moreover, physicochemical properties that confer physiological advantages and contribute to the control and inhibition of infectious diseases have been discussed. Safety concerns limit the commercial production and clinical use of these technologies in humans; however, overcoming these limitations may enable the use of nanomaterials to resolve current infection control issues via application of nanomaterials as a platform for the diagnosis, prevention, and treatment of viral diseases.

AB - The coronavirus disease (COVID-19) pandemic poses serious global health concerns with the continued emergence of new variants. The periodic outbreak of novel emerging and re-emerging infectious pathogens has elevated concerns and challenges for the future. To develop mitigation strategies against infectious diseases, nano-based approaches are being increasingly applied in diagnostic systems, prophylactic vaccines, and therapeutics. This review presents the properties of various nanoplatforms and discusses their role in the development of sensors, vectors, delivery agents, intrinsic immunostimulants, and viral inhibitors. Advanced nanomedical applications for infectious diseases have been highlighted. Moreover, physicochemical properties that confer physiological advantages and contribute to the control and inhibition of infectious diseases have been discussed. Safety concerns limit the commercial production and clinical use of these technologies in humans; however, overcoming these limitations may enable the use of nanomaterials to resolve current infection control issues via application of nanomaterials as a platform for the diagnosis, prevention, and treatment of viral diseases.

UR - http://www.scopus.com/inward/record.url?scp=85116002163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85116002163&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics13101570

DO - 10.3390/pharmaceutics13101570

M3 - Review article

AN - SCOPUS:85116002163

SN - 1999-4923

VL - 13

JO - Pharmaceutics

JF - Pharmaceutics

IS - 10

M1 - 1570

ER -

Application of nanomaterials as an advanced strategy for the diagnosis, prevention, and treatment of viral diseases

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this